Gufic Biosciences (BOM:509079) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Gufic Biosciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Gufic Biosciences's Free Cash Flow for the three months ended in Sep. 2024 was ₹0 Mil. Gufic Biosciences's Revenue for the three months ended in Sep. 2024 was ₹2,042 Mil. Therefore, Gufic Biosciences's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Gufic Biosciences's current FCF Yield % is -2.72%.

The historical rank and industry rank for Gufic Biosciences's FCF Margin % or its related term are showing as below:

BOM:509079' s FCF Margin % Range Over the Past 10 Years
Min: -31.51 Med: -2.5 Max: 15.35
Current: -15.67

During the past 13 years, the highest FCF Margin % of Gufic Biosciences was 15.35%. The lowest was -31.51%. And the median was -2.50%.

BOM:509079's FCF Margin % is ranked worse than
76.54% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs BOM:509079: -15.67

Gufic Biosciences FCF Margin % Historical Data

The historical data trend for Gufic Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences FCF Margin % Chart

Gufic Biosciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

1.91

15.35

2.63

-31.51

-15.61

Gufic Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gufic Biosciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Gufic Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gufic Biosciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gufic Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Gufic Biosciences's FCF Margin % falls into.

Gufic Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Gufic Biosciences's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-1201.516	/	7696.562
	=	-15.61 %

Gufic Biosciences's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0	/	2041.799
	=	0.00 %

Gufic Biosciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (BOM:509079) » Definitions » FCF Margin %

Traded in Other Exchanges

GUFICBIO:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines